Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1055


Advances in Coronary Angioplasty: Drug Eluting Stents


Description: The development of drug-eluting stents has emerged since the use of stenting became particularly prevalent, especially in the US. Stents are currently used in approximately 70%-90% of cardiovascular interventional procedures and have been shown to reduce the need for repeat percutaneous transluminal coronary angioplasty (Ptca) due to restenosis. There are, however, issues of in-stent thrombosis and in-stent restenosis that need to be addressed when analyzing the results of clinical trial data. Over the next few years, additional long-term studies will aim to provide details of the long-term outcome for drug-eluting stents. In light of recent advances in this field of research, this brief sets out to: *describe the stenting procedure and outline the overall use of stents in coronary interventional procedures *outline recent advances in procedures, such as brachytherapy and sonotherapy, and establish the main advantages and disadvantages of each type of intervention *analyze clinical trial data and company strategies for key drug-eluting stent programs, including in-depth review of sirolimus-eluting, paclitaxel-eluting and actinomycin D-eluting stent trials *compare drug-eluting stent developments against established interventions in order to determine the potential success and patient population for drug-eluting stents *provide a forecasted market size for the drug-eluting stent market to 2005, along with an identification of the key factors influencing the market during this period * analyze the potential impact of drug-eluting stents on pharmaceutical companies, in terms of the affect on the use of anti-thrombotic and anti restenotic agents.


Contents:
Datamonitor Healthcare


CONTACT DETAILS



TABLE OF CONTENTS


EXECUTIVE SUMMARY






Introduction


The history of angioplasty


Current use of stents in interventional therapy


Definition of stenting














In-stent restenosis


Increased intervention costs


Epidemiology overview


Percutaneous transluminal coronary angioplasty (PTCA)


Recent advances in stent therapy


Brachytherapy


Sonotherapy


Coated stents


Radioactive stents


Pipeline for drug-eluting stents


Sirolimus-eluting stent


RAVEL: zero restenosis


Cypher: Is it really too good to be true?


Will drug-eluting stents prove too costly?


Potential strategic alliances for Cordis


Market implications of drug-eluting stents


Paclitaxel-eluting stents


SCORE trial terminated


Increasing presence in the medical device market


Initial results from the paclitaxel-eluting stent trial


Strategic alliances to maximize potential revenue


Actinomycin D-eluting stent


Comparative analysis


Competition between drug-eluting stents


Market forecasts for drug-eluting stents


Potential impact on antithrombotic drug therapy?


Appendix


Bibliography








Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1055

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 22/11/2009 02:53:42
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Advances in Coronary Angioplasty: Drug Eluting Stents

Web Address:
http://www.researchandmarkets.com/reports/1055

Office Code:
OC8HJMRPRTPXY

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Hard Copy €1,048.00 + EUR€ 50.00 Shipping/Handling *
Electronic €1,008.00
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 22/11/2009 02:53:42


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)